Literature DB >> 12623193

Improvement of the dissolution rate of artemisinin by means of supercritical fluid technology and solid dispersions.

T Van Nijlen1, K Brennan, G Van den Mooter, N Blaton, R Kinget, P Augustijns.   

Abstract

The purpose of this study was to enhance the dissolution rate of artemisinin in order to improve the intestinal absorption characteristics. The effect of: (1) micronisation and (2) formation of solid dispersions with PVPK25 was assessed in an in vitro dissolution system [dissolution medium: water (90%), ethanol (10%) and sodium lauryl sulphate (0.1%)]. Coulter counter analysis was used to measure particle size. X-ray diffraction and DSC were used to analyse the physical state of the powders. Micronisation by means of a jet mill and supercritical fluid technology resulted in a significant decrease in particle size as compared to untreated artemisinin. All powders appeared to be crystalline. The dissolution rate of the micronised forms improved in comparison to the untreated form, but showed no difference in comparison to mechanically ground artemisinin. Solid dispersions of artemisinin with PVPK25 as a carrier were prepared by the solvent method. Both X-ray diffraction and DSC showed that the amorphous state was reached when the amount of PVPK25 was increased to 67%. The dissolution rate of solid dispersions with at least 67% of PVPK25 was significantly improved in comparison to untreated and mechanically ground artemisinin. Modulation of the dissolution rate of artemisinin was obtained by both particle size reduction and formation of solid dispersions. The effect of particle size reduction on the dissolution rate was limited. Solid dispersions could be prepared by using a relatively small amount of PVPK25. The formation of solid dispersions with PVPK25 as a carrier appears to be a promising method to improve the intestinal absorption characteristics of artemisinin. Copyright 2003 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12623193     DOI: 10.1016/s0378-5173(03)00009-7

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  7 in total

Review 1.  Supercritical Fluid Technology: An Emphasis on Drug Delivery and Related Biomedical Applications.

Authors:  Ranjith Kumar Kankala; Yu Shrike Zhang; Shi-Bin Wang; Chia-Hung Lee; Ai-Zheng Chen
Journal:  Adv Healthc Mater       Date:  2017-07-28       Impact factor: 9.933

2.  Rosuvastatin calcium nanoparticles: Improving bioavailability by formulation and stabilization codesign.

Authors:  Doaa H Alshora; Mohamed A Ibrahim; Ehab Elzayat; Osaid T Almeanazel; Fars Alanazi
Journal:  PLoS One       Date:  2018-07-09       Impact factor: 3.240

3.  A Repurposed Drug for Brain Cancer: Enhanced Atovaquone Amorphous Solid Dispersion by Combining a Spontaneously Emulsifying Component with a Polymer Carrier.

Authors:  Hiroyuki Takabe; Zachary N Warnken; Yajie Zhang; Daniel A Davis; Hugh D C Smyth; John G Kuhn; Steve Weitman; Robert O Williams Iii
Journal:  Pharmaceutics       Date:  2018-05-19       Impact factor: 6.321

4.  Applying Supercritical Fluid Technology to Prepare Ibuprofen Solid Dispersions with Improved Oral Bioavailability.

Authors:  Fei Han; Wei Zhang; Ying Wang; Ziyue Xi; Lu Chen; Sanming Li; Lu Xu
Journal:  Pharmaceutics       Date:  2019-02-03       Impact factor: 6.321

5.  Defining the process parameters affecting the fabrication of rosuvastatin calcium nanoparticles by planetary ball mill.

Authors:  Doaa Alshora; Mohamed Ibrahim; Ehab Elzayat; Osaid T Almeanazel; Fars Alanazi
Journal:  Int J Nanomedicine       Date:  2019-06-27

Review 6.  Supercritical fluid technology for solubilization of poorly water soluble drugs via micro- and naonosized particle generation.

Authors:  Shashi Kiran Misra; Kamla Pathak
Journal:  ADMET DMPK       Date:  2020-06-29

7.  Enhancement of the dissolution rate and bioavailability of fenofibrate by a melt-adsorption method using supercritical carbon dioxide.

Authors:  Kwang-Ho Cha; Kyung-Jin Cho; Min-Soo Kim; Jeong-Soo Kim; Hee Jun Park; Junsung Park; Wonkyung Cho; Jeong-Sook Park; Sung-Joo Hwang
Journal:  Int J Nanomedicine       Date:  2012-10-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.